keynote001
This is an old revision of the document!
The 2015 KEYNOTE-001 Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
The 2015 KEYNOTE-001 Adverse Effects
keynote001.1675841293.txt.gz · Last modified: 2025/02/01 17:00 (external edit)